Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|December 12, 2018
Hyperthermia in cervical cancer - current statusEwa Burchardt, Andrzej RoszakJournal of Personalized Medicine|October 27, 2022
Tumour-Related Parameters as a Prognostic Factor in Patients with Advanced Cervical Cancer: 20-Year Follow-Up of Diagnostic and Treatment Changes during ChemioradiotherapyZaneta Warenczak-Florczak, Ewa Burchardt, Agnieszka Wilk, et al.Contemporary Oncology (Poznan, Poland)|December 5, 2019
The effect of different segmentation methods on primary tumour metabolic volume assessed in <sup>18</sup>F-FDG-PET/CT in patients with cervical cancer, for radiotherapy planningPaulina Cegła, Ewa Burchardt, Ewa Wierzchosławska, et al.Klinika Oczna|March 31, 2004
[The results of diode treatment of active phase of retinopathy of prematurity]Anna Gotz-Wieckowska, Jarosław Kociecki, Ewa Burchardt-Kroll, et al.Nuklearmedizin. Nuclear Medicine|February 16, 2019
Influence of 18F-FDG-PET/CT on staging of cervical cancerPaulina Cegla, Bartosz Urbanski, Ewa Burchardt, et al.Diagnostics (Basel, Switzerland)|April 30, 2021
Pretreatment [<sup>18</sup>F]FDG PET/CT Prognostic Factors in Patients with Squamous Cell Cervical Carcinoma FIGO IIIC1Ewa Burchardt, Wojciech Burchardt, Paulina Cegła, et al.Clinical Nuclear Medicine|July 27, 2019
Influence of Biological Parameters Assessed in [18F]FDG PET/CT on Overall Survival in Cervical Cancer PatientsPaulina Cegla, Ewa Burchardt, Andrzej Roszak, et al.Journal of Contemporary Brachytherapy|January 24, 2020
Reducing dysphagia with palliative 2D high-dose-rate brachytherapy improves survival in esophageal cancerWojciech Burchardt, Artur Chyrek, Ewa Burchardt, et al.Klinika Oczna|August 4, 2006
[The analysis of failure diode laser treatment of active phase of retinopathy of prematurity]Anna Gotz-Wieckowska, Małgorzata Rydlewska-Fojut, Agnieszka Siennicka, et al.Journal of Contemporary Brachytherapy|May 22, 2023
The potential of low-dose-rate brachytherapy with iodine-125 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapyWojciech M Burchardt, Artur J Chyrek, Grzegorz M Bielęda, et al.Pageof 3